Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intérêt de l'électroporation irréversible Dans le Traitement de l'adénocarcinome du pancréas

NCT03105921 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT03105921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03105921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intérêt de l'électroporation irréversible Dans le Traitement de l'adénocarcinome du pancréas
Lead sponsor
Poitiers University Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 24, 2014
Completion date
April 1, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interventional imaging, pancreatic adenocarcinoma